Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for NeueHealth Inc. (NEUE:NYSE), powered by AI.
NeueHealth Inc. is currently trading at $6.75. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for NeueHealth Inc. on Alpha Lenz.
NeueHealth Inc.'s P/E ratio is -0.4.
“NeueHealth Inc. trades at a P/E of -0.4 (undervalued) with strong ROE of 34.6%.”
Ask for details →NeueHealth Inc. is a healthcare-focused company dedicated to improving patient outcomes through innovative solutions and services. Its primary function is to deliver value-based healthcare that emphasizes efficiency and quality care for patients. NeueHealth Inc. offers a variety of services, including healthcare management, medical billing, and consulting, aimed at optimizing the operations of healthcare providers. With a focus on technology integration, the company impacts sectors such as hospitals, clinics, and insurance entities by streamlining processes and improving data accuracy. In the broader financial market, NeueHealth Inc. plays a significant role in the healthcare industry's transition towards more sustainable and patient-centered models, contributing to cost efficiency and enhanced care delivery. This positions NeueHealth as a crucial player in shaping the future of healthcare management and delivery systems.
“NeueHealth Inc. trades at a P/E of -0.4 (undervalued) with strong ROE of 34.6%.”
Ask for details →NeueHealth Inc. (ticker: NEUE) is a company listed on NYSE in the Healthcare sector (Healthcare Plans). It has approximately 986 employees. Market cap is $56M.
The current price is $6.753 with a P/E ratio of -0.41x and P/B of -0.13x.
ROE is 34.61% and operating margin is -10.15%. Annual revenue is $937M.